|
6/08/23
|
IDEAYA Biosciences, a clinical-stage precision medicine oncology company, inked a long-term lease for 44k sf of space at 5000 Shoreline Court. Owned by DivcoWest, 5000 Shoreline Court is a 140k sf, Class A building on the bay in South San Francisco’s Sierra Point life science cluster.
The lease gives IDEAYA access to state-of-the art lab space designed specifically for the firm’s needs and growth plans. Move in is expected in mid-2024.
DivcoWest acquired 5000 Shoreline Court last year as a vacant office building and immediately put in place a plan to convert the waterfront property to high quality lab use, upgrading building systems and infrastructure to appeal to life science users. The life science cluster surrounding the building is dominated by dozens of world-class life science ventures including AstraZeneca, Bristol Myers Squibb, and Janssen Pharmaceuticals.
Base building improvements include upgrading the electrical service to 4000 amps, replacing of rooftop mechanical units and the addition of a 1,200kW emergency generator. DivcoWest is installing two additional service elevators, a new gym as well as upgrading the building’s common areas to include meeting spaces.
The three-story building can accommodate tenants from 10k sf to 80k sf. DivcoWest is in the process of fitting out 10k sf, 13k sf, and 20k sf spec suites offering lab space, lab support areas, offices, conference rooms, lounges, and lobbies. Spec suites will be available for occupancy in Q1 2024.
5000 Shoreline Court offers abundant parking and is less than a 15-minute drive from downtown San Francisco and ten minutes to SFO. The building’s waterfront location also puts it on the San Francisco Bay Trail, a 350-mile network of connected walking trails, bike paths and parks. The trail provides foot and bike access to the Alameda-Oakland-South San Francisco ferry situated just across the Oyster Point Channel.
DivcoWest was represented in the transaction by Chris Jacobs and Matt Jacobs of CBRE. IDEAYA Biosciences was repped by Grant Dettmer and Scott Miller of JLL.
|
|
Return to the Archive page
|
|
|
|
|